Table 2.
Participants | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Level | Repetitions | Level | Rounds | Repetitions | Level | Repetitions | Level | Repetitions | Level | Minutes | |
Women | |||||||||||
Participant #1 | Scale | 297 | Scale | 5 | 430 | Scaled | 143 | Scale | 278 | Scale | 13.78 |
Participant #2 | Scale | 216 | Rx | 1 | 79 | Rx | 10 | Scale | 165 | Rx | 18.38 |
Participant #3 | Scale | 135 | Scale | 4 | 348 | Scale | 49 | Scale | 121 | Rx | 26.98 |
Participant #4 | Scale | 218 | Rx | 2 | 20 | Scale | 108 | Rx | 165 | Rx | 19.93 |
Participant #5 | Rx | 669 | Rx | 2 | 167 | Rx | 58 | Scale | 217 | Rx | 15.25 |
Mean ± SD | 307 ± 210 | 3 ± 2 | 209 ± 175 | 74 ± 52 | 189 ± 60 | 18.87 ± 5.15 | |||||
Men | |||||||||||
Participant #6 | Rx | 685 | Rx | 2 | 165 | Rx | 75 | Rx | 178 | - | - |
Participant #7 | Rx | 791 | Rx | 2 | 173 | Rx | 90 | Rx | 199 | Rx | 13.47 |
Participant #8 | Rx | 681 | Rx | 2 | 172 | Rx | 71 | Rx | 184 | Rx | 14.47 |
Participant #9 | Rx | 681 | Rx | 2 | 175 | Rx | 75 | Rx | 182 | Rx | 18.38 |
Participant #10 | Rx | 720 | Rx | 2 | 126 | Rx | 89 | Rx | 193 | - | - |
Mean ± SD | 719 ± 51 | 2 ± 0 | 162 ± 21 | 80 ± 9 | 187 ± 9 | - | 15.44 ± 2.60 | ||||
All Participants | 490 ± 265 | 2 ± 1 | 186 ± 120 | 77 ± 35 | 188 ± 41 | 17.58 ± 4.50 |